Abstract
Background
As a reflection of the increasing global incidence of obesity, there is a corresponding increase in the proportion of obese patients undergoing bariatric surgery. This study reviewed the factors and outcomes of patients who underwent bariatric surgical procedures and determined the relationships and developed a nomogram to calculate individualized patient risk.
Methods
The nomogram was based on a retrospective study on 259 patients who underwent bariatric surgery at the Chengdu Third People’s Hospital from June 2017 to June 2019. The predictive accuracy and discriminative ability of the nomogram were determined by the ROC curve and C-index, respectively. The results were validated using bootstrap resampling and a retrospective study on 121 patients operated on from May 2015 to May 2019 at the Tenth People’s Hospital of Shanghai.
Results
The predictors contained in the prediction nomogram included age, sex, surgical approach, hyperlipidemia, blood pressure (BP), hyperuricemia, body mass index (BMI), and waist circumference (WC). The 6-month model displayed good discrimination with a C-index of 0.765 (95% CI: 0.756 to 0.774) and good calibration. The 1-year model reached a C-index of 0.768 (95% CI, 0.759 to 0.777) in the training cohort.
Conclusions
The proposed nomogram resulted in more accurate non-remission prediction for patients with obesity after bariatric surgery and may provide a reference for the preoperative choice of surgical methods.
Similar content being viewed by others
Data Availability
The datasets analyzed during the current study are available from the corresponding author on reasonable request.
References
NCD Risk Factor Collaboration (NCD-RisC). Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants. Lancet. 2016;387(10026):1377–96.
Wang Y, Xue H, Sun M, et al. Prevention and control of obesity in China. Lancet Glob Health. 2019;7(9):e1166–1166e1167.
Wang Y, Lobstein T. Worldwide trends in childhood overweight and obesity. Int J Pediatr Obes. 2006;1(1):11–25.
Wang Y, Mi J, Shan XY, et al. Is China facing an obesity epidemic and the consequences? The trends in obesity and chronic disease in China. Int J Obes (Lond). 2007;31(1):177–88.
Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014;384(9945):766–81.
Wang Y, Wang L, Qu W. New national data show alarming increase in obesity and noncommunicable chronic diseases in China. Eur J Clin Nutr. 2017;71(1):149–50.
Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric surgery versus intensive medical therapy for diabetes - 5-year outcomes. N Engl J Med. 2017;376(7):641–51.
Chang SH, Stoll CR, Song J, et al. The effectiveness and risks of bariatric surgery: an updated systematic review and meta-analysis, 2003–2012. JAMA Surg. 2014;149(3):275–87.
Buchwald H, Oien DM. Metabolic/bariatric surgery worldwide 2011. Obes Surg. 2013;23(4):427–36.
Inge TH, Courcoulas AP, Jenkins TM, et al. Five-year outcomes of gastric bypass in adolescents as compared with adults. N Engl J Med. 2019;380(22):2136–45.
Peterli R, Wölnerhanssen BK, Peters T, et al. Effect of laparoscopic sleeve gastrectomy vs laparoscopic Roux-en-Y gastric bypass on weight loss in patients with morbid obesity: the SM-BOSS randomized clinical trial. JAMA. 2018;319(3):255–65.
Nasser H, Ivanics T, Leonard-Murali S, et al. Perioperative outcomes of laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy in super-obese and super-super-obese patients: a national database analysis. Surg Obes Relat Dis. 2019;15(10):1696–703.
Arterburn D, Wellman R, Emiliano A, et al. Comparative effectiveness and safety of bariatric procedures for weight loss: a PCORnet cohort study. Ann Intern Med. 2018;169(11):741–50.
Poelemeijer Y, Liem R, Våge V, et al. Gastric bypass versus sleeve gastrectomy: patient selection and short-term outcome of 47,101 primary operations from the Swedish, Norwegian, and Dutch national quality registries. Ann Surg. 2019;
Turner PL, Saager L, Dalton J, et al. A nomogram for predicting surgical complications in bariatric surgery patients. Obes Surg. 2011;21(5):655–62.
Liu J, Zhou H, Zhang Y, et al. Nomogram for patients with stage I small cell lung cancer: a competing risk analysis. Ann Oncol. 2019;30(Suppl 2):ii22.
Maurichi A, Miceli R, Eriksson H, et al. Factors affecting sentinel node metastasis in thin (T1) cutaneous melanomas: development and external validation of a predictive nomogram. J Clin Oncol. 2020:JCO1901902.
Sternberg CN. Are nomograms better than currently available stage groupings for bladder cancer. J Clin Oncol. 2006;24(24):3819–20.
Mariani L, Miceli R, Kattan MW, et al. Validation and adaptation of a nomogram for predicting the survival of patients with extremity soft tissue sarcoma using a three-grade system. Cancer. 2005;103(2):402–8.
Wang L, Hricak H, Kattan MW, et al. Prediction of organ-confined prostate cancer: incremental value of MR imaging and MR spectroscopic imaging to staging nomograms. Radiology. 2006;238(2):597–603.
American Diabetes Association. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2020. Diabetes Care. 2020;43(Suppl 1):S14–14S31.
Casey Jr DE, Thomas RJ, Bhalla V, et al. 2019 AHA/ACC Clinical performance and quality measures for adults with high blood pressure: a report of the American College of Cardiology/American Heart Association Task Force on performance measures. J Am Coll Cardiol. 2019;74(21):2661–706.
Multidisciplinary Expert Task Force on Hyperuricemia and Related Diseases. Chinese multidisciplinary expert consensus on the diagnosis and treatment of hyperuricemia and related diseases. Chin Med J (Engl). 2017;130(20):2473–88.
Grundy SM, Stone NJ. Guideline Writing Committee for the 2018 Cholesterol Guidelines. 2018 Cholesterol Clinical Practice Guidelines: Synopsis of the 2018 American Heart Association/American College of Cardiology/Multisociety Cholesterol Guideline. Ann Intern Med. 2019;170(11):779–83.
Tobias DK, Pan A, Jackson CL, et al. Body-mass index and mortality among adults with incident type 2 diabetes. N Engl J Med. 2014;370(3):233–44.
Weigley ES. Average? Ideal? Desirable? A brief overview of height-weight tables in the United States. J Am Diet Assoc. 1984;84(4):417–23.
Sauerbrei W, Royston P, Binder H. Selection of important variables and determination of functional form for continuous predictors in multivariable model building. Stat Med. 2007;26(30):5512–28.
Friedman J, Hastie T, Tibshirani R. Regularization paths for generalized linear models via coordinate descent. J Stat Softw. 2010;33(1):1–22.
Kidd AC, McGettrick M, Tsim S, et al. Survival prediction in mesothelioma using a scalable Lasso regression model: instructions for use and initial performance using clinical predictors. BMJ Open Respir Res. 2018;5(1):e000240.
Xing J, Min L, Zhu S, et al. Factors associated with gastric adenocarcinoma and dysplasia in patients with chronic gastritis: a population-based study. Chin J Cancer Res. 2017;29(4):341–50.
Kramer AA, Zimmerman JE. Assessing the calibration of mortality benchmarks in critical care: the Hosmer-Lemeshow test revisited. Crit Care Med. 2007;35(9):2052–6.
Westeneng HJ, Debray T, Visser AE, et al. Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model. Lancet Neurol. 2018;17(5):423–33.
GBD 2015 Obesity Collaborators, Afshin A, Forouzanfar MH, et al. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med. 2017;377(1):13–27.
Zheng Y, Manson JE, Yuan C, et al. Associations of weight gain from early to middle adulthood with major health outcomes later in life. JAMA. 2017;318(3):255–69.
Fernández-Soto ML, Martín-Leyva A, González-Jiménez A, et al. Remission of type 2 diabetes mellitus after bariatric surgery - comparison between procedures. Endokrynol Pol. 2017;68(1):18–25.
Puzziferri N, Roshek 3rd TB, Mayo HG, et al. Long-term follow-up after bariatric surgery: a systematic review. JAMA. 2014;312(9):934–42.
Maggard-Gibbons M, Maglione M, Livhits M, et al. Bariatric surgery for weight loss and glycemic control in nonmorbidly obese adults with diabetes: a systematic review. JAMA. 2013;309(21):2250–61.
Grover BT, Morell MC, Kothari SN, et al. Defining weight loss after bariatric surgery: a call for standardization. Obes Surg. 2019;29(11):3493–9.
van de Laar AW, van Rijswijk AS, Kakar H, et al. Sensitivity and specificity of 50% excess weight Loss (50%EWL) and twelve other bariatric criteria for weight loss success. Obes Surg. 2018;28(8):2297–304.
Wu J, Ye H, Wang Y, et al. Comparative study of laparoscopic sleeve gastrectomy with and without partial enterectomy and omentectomy. Surg Obes Relat Dis. 2012;8(3):275–80.
Vilallonga R, Hidalgo M, Garcia Ruiz de Gordejuela A, et al. Operative and postoperative complications of laparoscopic sleeve gastrectomy in super and nonsuper obese patients: a center of excellence experience comparative study. J Laparoendosc Adv Surg Tech A. 2020;
Grundy SM. Metabolic syndrome update. Trends Cardiovasc Med. 2016;26(4):364–73.
Petrick AT, Kuhn JE, Parker DM, et al. Bariatric surgery is safe and effective in Medicare patients regardless of age: an analysis of primary gastric bypass and sleeve gastrectomy outcomes. Surg Obes Relat Dis. 2019;15(10):1704–11.
Kochkodan J, Telem DA, Ghaferi AA. Physiologic and psychological gender differences in bariatric surgery. Surg Endosc. 2018;32(3):1382–8.
Wee CC, Huskey KW, Bolcic-Jankovic D, et al. Sex, race, and consideration of bariatric surgery among primary care patients with moderate to severe obesity. J Gen Intern Med. 2014;29(1):68–75.
Menenakos E, Doulami G, Tzanetakou IP, et al. The use of serum uric acid concentration as an indicator of laparoscopic sleeve gastrectomy success. Int Surg. 2015;100(1):173–9.
Nickel F, de la Garza JR, Werthmann FS, et al. Predictors of risk and success of obesity surgery. Obes Facts. 2019;12(4):427–39.
Masrur M, Bustos R, Sanchez-Johnsen L, et al. Factors associated with weight loss after metabolic surgery in a multiethnic sample of 1012 patients. Obes Surg. 2020;30(3):975–81.
Acknowledgments
The authors would like to thank the efforts of the medical staff who followed the patients in the Third People’s Hospital of Chengdu and the Tenth People’s Hospital of Shanghai. In addition, we would also like to appreciate Professor Liu Qi of Tongji University for his help in the statistical analysis of this study.
Funding
This work was supported by grants from the National Natural Science Foundation of China (81502075) and the Foundation of Science and Technology of Sichuan Province (2019YJ0635). The funders had no role in the study design or implementation.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
The protocol for this study was approved by the Ethics Committee of the Chengdu Third People’s Hospital (record #: 2018S75; Chengdu, Sichuan, China) and was conducted in accordance with the Chinese ethical guidelines for human genome/gene research.
Conflict of Interest
The authors declare that they have no conflict of interest.
Statement of Informed Consent
Additional informed consent was obtained from all individual participants for whom identifying information is included in this article.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
ESM 1
(DOCX 798 kb)
Rights and permissions
About this article
Cite this article
Mao, R., Guo, P., Lin, Z. et al. Nomograms for Predicting Non-remission in Patients Who Underwent Bariatric Surgery: A Multicenter Retrospective Study in China. OBES SURG 31, 1967–1978 (2021). https://doi.org/10.1007/s11695-020-05206-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11695-020-05206-8